Czech National Bank raised its holdings in The Allstate Co. (NYSE:ALL - Free Report) by 6.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 57,415 shares of the insurance provider's stock after purchasing an additional 3,628 shares during the period. Czech National Bank's holdings in Allstate were worth $11,069,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the business. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Allstate by 0.4% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 97,567 shares of the insurance provider's stock worth $18,503,000 after purchasing an additional 397 shares during the last quarter. International Assets Investment Management LLC acquired a new stake in shares of Allstate in the fourth quarter worth approximately $14,518,000. Peoples Bank KS purchased a new stake in Allstate in the fourth quarter valued at approximately $49,000. Boltwood Capital Management increased its position in Allstate by 10.5% during the fourth quarter. Boltwood Capital Management now owns 7,710 shares of the insurance provider's stock worth $1,486,000 after purchasing an additional 730 shares during the last quarter. Finally, Nordea Investment Management AB grew its stake in shares of Allstate by 1.2% during the 4th quarter. Nordea Investment Management AB now owns 54,086 shares of the insurance provider's stock valued at $10,397,000 after buying an additional 631 shares during the period. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Allstate Stock Performance
Shares of ALL traded up $4.33 during midday trading on Tuesday, hitting $186.87. 1,554,053 shares of the stock traded hands, compared to its average volume of 2,377,679. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The Allstate Co. has a 1-year low of $150.17 and a 1-year high of $209.88. The business's 50 day moving average price is $195.85 and its two-hundred day moving average price is $185.88. The firm has a market capitalization of $49.48 billion, a PE ratio of 12.10, a price-to-earnings-growth ratio of 1.70 and a beta of 0.52.
Allstate (NYSE:ALL - Get Free Report) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The firm had revenue of $16.63 billion during the quarter, compared to analysts' expectations of $14.57 billion. During the same quarter in the prior year, the firm earned $0.81 EPS. Allstate's quarterly revenue was up 14.7% on a year-over-year basis. Equities research analysts predict that The Allstate Co. will post 16.26 EPS for the current fiscal year.
Allstate Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th were paid a $0.92 dividend. The ex-dividend date of this dividend was Friday, November 29th. This represents a $3.68 annualized dividend and a dividend yield of 1.97%. Allstate's payout ratio is 23.83%.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on ALL shares. Piper Sandler lifted their target price on Allstate from $206.00 to $244.00 and gave the company an "overweight" rating in a report on Tuesday, November 26th. Raymond James lifted their price objective on Allstate from $205.00 to $220.00 and gave the company a "strong-buy" rating in a research note on Friday, October 4th. UBS Group increased their target price on shares of Allstate from $216.00 to $225.00 and gave the stock a "buy" rating in a research report on Monday, November 4th. BMO Capital Markets boosted their price objective on shares of Allstate from $205.00 to $214.00 and gave the stock an "outperform" rating in a research note on Friday, October 18th. Finally, Jefferies Financial Group upped their target price on Allstate from $231.00 to $267.00 and gave the stock a "buy" rating in a research report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $218.13.
Check Out Our Latest Research Report on ALL
Allstate Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.